Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Leif Bergsagel

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Where we were, where we are, where we are going: progress in multiple myelomaP Leif Bergsagel
Clinical Lymphoma & Myeloma|June 29, 2007
Individualizing therapy using molecular markers in multiple myelomaP Leif Bergsagel
Hematology. American Society of Hematology. Education Program|December 14, 2011
Many multiple myelomas: making more of the molecular mayhemMarta Chesi, P Leif Bergsagel
Cancer Cell|October 19, 2010
Epigenetics and microRNAs combine to modulate the MDM2/p53 axis in myelomaMarta Chesi, P Leif Bergsagel
International Journal of Hematology|March 5, 2013
Molecular pathogenesis of multiple myeloma: basic and clinical updatesMarta Chesi, P Leif Bergsagel
Immunological Reviews|July 9, 2003
Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myelomaP Leif Bergsagel, W Michael Kuehl
The Journal of Clinical Investigation|October 2, 2012
Molecular pathogenesis of multiple myeloma and its premalignant precursorW Michael Kuehl, P Leif Bergsagel
Cancer Cell|July 12, 2011
Comprehensive identification of somatic mutations in chronic lymphocytic leukemiaP Leif Bergsagel, W Michael Kuehl
Nature Reviews. Cancer|May 7, 2002
Multiple myeloma: evolving genetic events and host interactionsW Michael Kuehl, P Leif Bergsagel
Blood Cancer Discovery|October 18, 2021
Promiscuous Structural Variants Drive Myeloma Initiation and ProgressionP Leif Bergsagel, W Michael Kuehl
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Where we were, where we are, where we are going: progress in multiple myelomaP Leif Bergsagel
Clinical Lymphoma & Myeloma|June 29, 2007
Individualizing therapy using molecular markers in multiple myelomaP Leif Bergsagel
Hematology. American Society of Hematology. Education Program|December 14, 2011
Many multiple myelomas: making more of the molecular mayhemMarta Chesi, P Leif Bergsagel
Cancer Cell|October 19, 2010
Epigenetics and microRNAs combine to modulate the MDM2/p53 axis in myelomaMarta Chesi, P Leif Bergsagel
International Journal of Hematology|March 5, 2013
Molecular pathogenesis of multiple myeloma: basic and clinical updatesMarta Chesi, P Leif Bergsagel
Immunological Reviews|July 9, 2003
Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myelomaP Leif Bergsagel, W Michael Kuehl
The Journal of Clinical Investigation|October 2, 2012
Molecular pathogenesis of multiple myeloma and its premalignant precursorW Michael Kuehl, P Leif Bergsagel
Cancer Cell|July 12, 2011
Comprehensive identification of somatic mutations in chronic lymphocytic leukemiaP Leif Bergsagel, W Michael Kuehl
Nature Reviews. Cancer|May 7, 2002
Multiple myeloma: evolving genetic events and host interactionsW Michael Kuehl, P Leif Bergsagel
Blood Cancer Discovery|October 18, 2021
Promiscuous Structural Variants Drive Myeloma Initiation and ProgressionP Leif Bergsagel, W Michael Kuehl
Pageof 19